Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study … M Dinis-Ribeiro, M Areia, AC De Vries, R Marcos-Pinto, ... Endoscopy 44 (01), 74-94, 2012 | 1005 | 2012 |
Treatment of Helicobacter pylori Infection 2010 A O’Connor, JP Gisbert, D McNamara, C O’Morain Helicobacter 15, 46-52, 2010 | 412* | 2010 |
Sequential therapy for Helicobacter pylori eradication: a critical review JP Gisbert, X Calvet, A O'Connor, F Mégraud, CA O'Morain Journal of clinical gastroenterology 44 (5), 313-325, 2010 | 302 | 2010 |
Sequential therapy for Helicobacter pylori eradication: a critical review JP Gisbert, X Calvet, A O'Connor, F Mégraud, CA O'Morain Journal of clinical gastroenterology 44 (5), 313-325, 2010 | 302 | 2010 |
Population screening and treatment of Helicobacter pylori infection A O'connor, CA O'morain, AC Ford Nature Reviews Gastroenterology & Hepatology 14 (4), 230-240, 2017 | 199 | 2017 |
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a … SA Taylor, S Mallett, G Bhatnagar, R Baldwin-Cleland, S Bloom, A Gupta, ... The lancet Gastroenterology & hepatology 3 (8), 548-558, 2018 | 193 | 2018 |
Emerging treatments for inflammatory bowel disease K Hazel, A O’Connor Therapeutic advances in chronic disease 11, 2040622319899297, 2020 | 163 | 2020 |
Improving compliance with Helicobacter pylori eradication therapy: when and how? JPA O'Connor, I Taneike, C O'Morain Therapeutic advances in gastroenterology 2 (5), 273-279, 2009 | 134 | 2009 |
Sedation in digestive endoscopy: the Athens international position statements LB Cohen, SD Ladas, JJ Vargo, GA Paspatis, DJ Bjorkman, ... Alimentary pharmacology & therapeutics 32 (3), 425-442, 2010 | 109 | 2010 |
Treatment of Helicobacter pylori Infection 2011 A O’Connor, JP Gisbert, D McNamara, C O’Morain Helicobacter 16, 53-58, 2011 | 107 | 2011 |
Treatment of Helicobacter pylori Infection 2013 A O'Connor, J Molina‐Infante, JP Gisbert, C O'Morain Helicobacter 18, 58-65, 2013 | 103 | 2013 |
Treatment of Helicobacter pylori infection 2012 B Tepes, A O'Connor, JP Gisbert, C O'Morain Helicobacter 17, 36-42, 2012 | 95 | 2012 |
European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the … M Dinis-Ribeiro, M Areia, AC De Vries, R Marcos-Pinto, ... Endoscopy 44 (1), 74-94, 2012 | 95 | 2012 |
Review – Treatment of Helicobacter pylori infection 2020 A O'Connor, T Furuta, JP Gisbert, C O'Morain Helicobacter 25, e12743, 2020 | 93 | 2020 |
Treatment of Helicobacter pylori Infection 2014 A O'Connor, D Vaira, JP Gisbert, C O'Morain Helicobacter 19, 38-45, 2014 | 89* | 2014 |
Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis BM Flores, A O’Connor, AC Moss Gastrointestinal endoscopy 86 (6), 1006-1011. e8, 2017 | 86 | 2017 |
Treatment of Helicobacter pylori infection in 2018 NR O'Morain, MP Dore, AJP O'Connor, JP Gisbert, CA O'Morain Helicobacter 23, e12519, 2018 | 80 | 2018 |
Treatment of Helicobacter pylori Infection A O'Connor, J Gisbert, C O’Morain Helicobacter 14, 46-51, 2009 | 80 | 2009 |
Digestive function of the stomach A O'Connor, C O'Moráin Digestive diseases 32 (3), 186-191, 2014 | 73 | 2014 |
Treatment of Helicobacter pylori infection 2017 A O'Connor, D Lamarque, JP Gisbert, C O'Morain Helicobacter 22, e12410, 2017 | 71 | 2017 |